Related Experiment Video
Updated: May 28, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Clinical Application of Bacteriophage Therapy in Children
Nanda Ramchandar1,2,3,4, John S Bradley2,4
1Naval Medical Center San Diego, San Diego, California.
Insights
Bacteriophages offer a precise alternative to antibiotics for treating bacterial infections in children, preserving their microbiome. This review explores their potential in pediatric precision antimicrobial therapy.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Antimicrobial Therapy
Background:
- Bacteriophages are viruses that infect bacteria, offering high specificity for targeted pathogen elimination.
- Current research on bacteriophage therapy is extensive in adults, but data in pediatric populations remain limited.
- Antibiotic therapies can disrupt the beneficial pediatric microbiome, necessitating alternative treatments.
Purpose of the Study:
- To review bacteriophages as a novel antimicrobial approach for pediatric infections.
- To discuss the potential of bacteriophage therapy in precision medicine for children.
- To highlight research gaps and future directions for bacteriophage applications in pediatrics.
Main Methods:
- Literature review of bacteriophage therapy in adult and pediatric contexts.
- Discussion of bacteriophage specificity and microbiome-sparing effects.
- Exploration of practical considerations, limitations, and administration routes (topical and systemic).
Main Results:
- Bacteriophages demonstrate high specificity against target pathogens, minimizing collateral damage to the microbiome.
- Pediatric application presents an opportunity for precision antimicrobial strategies, especially for multidrug-resistant infections.
- Potential exists for bacteriophages as primary or adjunctive therapy in children.
Conclusions:
- Bacteriophage therapy holds significant promise for pediatric infectious diseases, offering a microbiome-sparing alternative.
- Further pediatric research is crucial to establish safety, efficacy, and optimal application protocols.
- This approach could revolutionize directed, precision antimicrobial treatments for infants and children.
Abstract:
Bacteriophages are highly specific in targeting single pathogens in the treatment of bacterial infections and thus offer a promising alternative to antibiotic therapies with the potential for essentially no impact to the child's own microbiome. Bacteriophages have been evaluated by investigators for several pathogens and tissue site infections in adults, but data in children are lacking. The application of this therapy in pediatrics provides an extraordinary opportunity to redesign our approach to directed, precision medicine antimicrobial therapy for infants and children for both acute infections and for chronic infections, particularly those caused by multidrug-resistant pathogens. In this therapeutic approach, a bacteriophage preparation would be selected exclusively for and limited to the patient's specific pathogen, thus minimizing the collateral damage to the child's microbiome, as often demonstrated with antibiotic therapy. In the following article, we describe these novel anti-infective biological agents, review the recent literature, discuss practical considerations and limitations, and share potential applications for both topical and systemic administration of bacteriophages, either as primary therapy or in combination with traditional antibiotics. Additionally, important areas of interest for pediatric research are discussed.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

